Illumina - Rising Treatment Numbers Continue to Drive Results!
Reading Time: 1 minute
Business drivers: The gene sequencing specialist Illumina (ILMN) has established itself as one of the technologically leading players in this growth market. With the help of the systems offered by Illumina, it is possible to determine the nucleotide sequence in a DNA molecule and analyze the corresponding data, whereby Illumina generates high margins primarily from the sale of high-end gene sequencing systems, as well as consumables and suitable analytic tools. In this context, a strategic partnership announced earlier this year with NVIDIA is...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

